NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $19,026 | 6.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $4,284,679 | 4.48% |
| ArchPoint Investors | 1,449,551 | $4,580,581 | 1.75% |
| Tikvah Management LLC | 1,313,895 | $4,151,908 | 1.49% |
| Perceptive Advisors | 9,111,151 | $28,791,237 | 0.96% |
| Cercano Management LLC | 7,172,985 | $22,666,633 | 0.81% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $6,320,000 | 0.71% |
| HILLMAN CO | 200,000 | $632,000 | 0.38% |
| Comprehensive Financial Management LLC | 2,207,619 | $6,976,076 | 0.25% |
| Clarius Group, LLC | 597,769 | $1,888,950 | 0.18% |
| Vanguard Capital Wealth Advisors | 46,000 | $145,360 | 0.14% |
| SENTINEL TRUST CO LBA | 300,000 | $948 | 0.13% |
| AMAZON COM INC | 1,457,055 | $4,604,294 | 0.11% |
| Clearline Capital LP | 264,903 | $837,094 | 0.07% |
| Alyeska Investment Group, L.P. | 445,986 | $1,409,316 | 0.01% |
| LAKE STREET ADVISORS GROUP, LLC | 27,590 | $87,000 | 0.01% |
| PDS Planning, Inc | 10,455 | $33,038 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 38,800 | $122,608 | 0.00% |
| SIGNATUREFD, LLC | 37,313 | $117,909 | 0.00% |
| China Universal Asset Management Co., Ltd. | 3,204 | $10 | 0.00% |
External links
This page lists NAUTILUS BIOTECHNOLOGY INC's shareholders in Q3 2023. To view NAUTILUS BIOTECHNOLOGY INC's shareholder history, click here.